Welcome to LookChem.com Sign In|Join Free
  • or
Home > Products >  > 

Stiripentol

Related Products

Hot Products

Name

Stiripentol

EINECS 256-480-9
CAS No. 49763-96-4 Density 1.139 g/cm3
PSA 38.69000 LogP 2.83550
Solubility N/A Melting Point 73-74 °C
Formula C14H18O3 Boiling Point 365.4 °C at 760 mmHg
Molecular Weight 234.295 Flash Point 174.8 °C
Transport Information N/A Appearance white solid
Safety Risk Codes 22
Molecular Structure Molecular Structure of 49763-96-4 (Stiripentol) Hazard Symbols Xn
Synonyms

1-(1,3-Benzodioxol-5-yl)-4,4-dimethyl-1-penten-3-ol;Estiripentol [INN-Spanish];4,4-Dimethyl-1-((3,4-methylenedioxy)phenyl)-1-penten-3-ol;1-Penten-3-ol, 4,4-dimethyl-1-(3,4-methylenedioxyphenyl)-;Stiripentol [USAN:INN];BCX 2600;1-Penten-3-ol, 1-(1,3-benzodioxol-5-yl)-4,4-dimethyl-;5-19-02-00640 (Beilstein Handbook Reference);Stiripentolum [INN-Latin];(E)-1-benzo[1,3]dioxol-5-yl-4,4-dimethyl-pent-1-en-3-ol;1-Penten-3-ol,1-(1,3-benzodioxol-5-yl)-4,4- dimethyl-;

Article Data 1

Stiripentol Specification

The IUPAC name of Stiripentol is (E)-1-(1,3-benzodioxol-5-yl)-4,4-dimethylpent-1-en-3-ol. With the CAS registry number 49763-96-4, it is also named as 4,4-Dimethyl-1-[(3,4-methylenedioxy)phenyl]-1-penten-3-ol. Besides, the product's categories are intermediates & fine chemicals and pharmaceuticals. It is white solid. Besides, its molecular formula is C14H18O3 and its molecular weight is 234.29. In adition, this chemical is an anticonvulsant drug used in the treatment of epilepsy. It also may be used to treat refractory childhood epilepsy in conjunction with carbamazepine.

The other characteristics of Stiripentol can be summarized as: (1)EINECS: 256-480-9; (2)ACD/LogP: 3.39; (3)# of Rule of 5 Violations: 0; (4)ACD/LogD (pH 5.5): 3.39; (5)ACD/LogD (pH 7.4): 3.39; (6)ACD/BCF (pH 5.5): 223.18; (7)ACD/BCF (pH 7.4): 223.18; (8)ACD/KOC (pH 5.5): 1670.23; (9)ACD/KOC (pH 7.4): 1670.23; (10)H bond acceptors: 3; (11)H bond donors: 1; (12)Freely Rotating Bonds: 4; (13)Polar Surface Area: 27.69 Å2; (14)Index of Refraction: 1.578; (15)Molar Refractivity: 68.29 cm3; (16)Molar Volume: 205.5 cm3; (17)Polarizability: 27.07×10-24cm3; (18)Surface Tension: 45.5 dyne/cm; (19)Density: 1.139 g/cm3; (20)Flash Point: 174.8 °C; (21)Melting Point: 73-74 °C; (22)Enthalpy of Vaporization: 64.54 kJ/mol; (23)Boiling Point: 365.4 °C at 760 mmHg; (24)Vapour Pressure: 5.54E-06 mmHg at 25 °C.

People can use the following data to convert to the molecule structure.
(1)SMILES:O1c2ccc(cc2OC1)/C=C/C(O)C(C)(C)C
(2)InChI:InChI=1/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+
(3)InChIKey:IBLNKMRFIPWSOY-FNORWQNLBD
(4)Std. InChI:InChI=1S/C14H18O3/c1-14(2,3)13(15)7-5-10-4-6-11-12(8-10)17-9-16-11/h4-8,13,15H,9H2,1-3H3/b7-5+
(5)Std. InChIKey:IBLNKMRFIPWSOY-FNORWQNLSA-N

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 1250mg/kg (1250mg/kg)   European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 13, Pg. 41, 1978.
mouse LD50 intravenous 72mg/kg (72mg/kg) BEHAVIORAL: ANTICONVULSANT Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 199, 1984.
mouse LD50 oral > 5gm/kg (5000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 199, 1984.
rat LD50 intraperitoneal 1471mg/kg (1471mg/kg) BEHAVIORAL: ANTICONVULSANT Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 199, 1984.
rat LD50 oral > 3gm/kg (3000mg/kg)   Arzneimittel-Forschung. Drug Research. Vol. 34, Pg. 199, 1984.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 49763-96-4